BioNTech and Bristol Myers Share ROSETTA Lung-02 Study Results
BioNTech (BNTX) and Bristol Myers have announced new results from their ROSETTA Lung-02 study. Details regarding the specific findings or implications of these results were not immediately available.
Pharmaceutical companies BioNTech (BNTX) and Bristol Myers have released new results from a clinical investigation known as the ROSETTA Lung-02 study.
The announcement indicates a development in the ongoing research efforts conducted by the two companies. Specific data points, the nature of the results, or any subsequent steps related to the study were not detailed in the available information.
(Source: Yahoo Finance)
Advertisement
AdSense slot • inline


